Trial site
Klinikum Region Hannover GmbH
- 18running trials
- 8closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Acute myeloid leukaemia4 trials
- Idiopathic pulmonary fibrosis4 trials
- Chronic kidney disease2 trials
- Multiple myeloma2 trials
- Diffuse large B-cell lymphoma1 trial
- Eosinophilic oesophagitis1 trial
- Follicular lymphoma1 trial
- Gastroparesis1 trial
- Head and neck cancer1 trial
- High blood pressure1 trial
- Hodgkin lymphoma1 trial
- and 2 more
- Phase
- Phase 320 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Recruiting11 trials
- Completed8 trials
- Active, not recruiting7 trials
- Lead sponsor
- AstraZeneca5 trials
- Boehringer Ingelheim3 trials
- Stichting Hemato-Oncologie voor Volwassenen Nederland2 trials
- AstraZeneca AB1 trial
- Celldex Therapeutics1 trial
- and 14 more
Running trials
Recruiting
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic kidney disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Head and neck cancer1 recruiting
- High blood pressure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
Completed
Completed
Completed
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
Completed
Completed
Completed
Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)
Site data: ClinicalTrials.govUpdated 17 Nov 2026